[go: up one dir, main page]

NO20084053L - Inhibition of tumor growth - Google Patents

Inhibition of tumor growth

Info

Publication number
NO20084053L
NO20084053L NO20084053A NO20084053A NO20084053L NO 20084053 L NO20084053 L NO 20084053L NO 20084053 A NO20084053 A NO 20084053A NO 20084053 A NO20084053 A NO 20084053A NO 20084053 L NO20084053 L NO 20084053L
Authority
NO
Norway
Prior art keywords
tumor growth
inhibition
lytic
vaccination
establishment
Prior art date
Application number
NO20084053A
Other languages
Norwegian (no)
Inventor
Oystein Rekdal
John Sigurd Svendsen
Baldur Sveinbjornsson
Gerd Berge
Live Tone Eliassen
Original Assignee
Lytix Biopharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lytix Biopharma As filed Critical Lytix Biopharma As
Publication of NO20084053L publication Critical patent/NO20084053L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer anvendelse av en lytisk forbindelse, spesielt et lytisk peptid, for fremstilling av et medikament for å fremkalle adaptiv immunitet mot tumorvekst eller etablering hos et individ, så vel som metoder for kreftbehandling og vaksinasjon.The present invention provides the use of a lytic compound, especially a lytic peptide, for the preparation of a medicament for inducing adaptive immunity to tumor growth or establishment in an individual, as well as methods of cancer treatment and vaccination.

NO20084053A 2006-03-21 2008-09-24 Inhibition of tumor growth NO20084053L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0605685.7A GB0605685D0 (en) 2006-03-21 2006-03-21 Inhibition of tumour growth
PCT/GB2007/000993 WO2007107748A2 (en) 2006-03-21 2007-03-21 Inhibition of tumour growth

Publications (1)

Publication Number Publication Date
NO20084053L true NO20084053L (en) 2008-11-28

Family

ID=36383910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084053A NO20084053L (en) 2006-03-21 2008-09-24 Inhibition of tumor growth

Country Status (8)

Country Link
EP (1) EP2010204A2 (en)
JP (1) JP2009530359A (en)
CN (1) CN101466391A (en)
AU (1) AU2007228574B2 (en)
CA (1) CA2646589C (en)
GB (1) GB0605685D0 (en)
NO (1) NO20084053L (en)
WO (1) WO2007107748A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0821616D0 (en) * 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
JP6813258B2 (en) * 2014-12-11 2021-01-13 リティックス バイオファーマ エイエス Chemotherapy combination
JP6767096B2 (en) 2014-12-11 2020-10-14 リティックス バイオファーマ エイエス Combination of immune checkpoint inhibitors
AU2016219161A1 (en) * 2015-02-12 2017-08-31 The Johns Hopkins University Inhibition of Yap for breaking tumor immune tolerance
GB201601868D0 (en) 2016-02-02 2016-03-16 Lytix Biopharma As Methods
WO2024133588A1 (en) 2022-12-20 2024-06-27 Lytix Biopharma As Compositions comprising an oncolytic peptide and chitosan
EP4637799A1 (en) 2022-12-20 2025-10-29 Lytix Biopharma AS Medical products containing an aqueous formulation of a peptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861478A (en) * 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
JP2962555B2 (en) * 1987-07-06 1999-10-12 ヘリックス バイオメディックス，インコーポレイテッド Suppression of eukaryotic pathogens and neoplasms by lytic peptides and stimulation of fibroblasts and lymphocytes
US5773413A (en) * 1993-06-04 1998-06-30 Demeter Biotechnologies, Ltd. Method of combating mammalian neoplasias, and lytic peptides therefor
IL113244A0 (en) * 1994-04-08 1995-07-31 Demeter Biotech Ltd Method of combating mammalian neoplasia and lytic peptides therefor
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides

Also Published As

Publication number Publication date
AU2007228574B2 (en) 2013-06-20
WO2007107748A3 (en) 2007-12-06
CA2646589C (en) 2016-05-03
AU2007228574A1 (en) 2007-09-27
JP2009530359A (en) 2009-08-27
CN101466391A (en) 2009-06-24
CA2646589A1 (en) 2007-09-27
GB0605685D0 (en) 2006-05-03
WO2007107748A2 (en) 2007-09-27
EP2010204A2 (en) 2009-01-07

Similar Documents

Publication Publication Date Title
NO20084053L (en) Inhibition of tumor growth
DOP2021000147A (en) THERAPEUTIC COMBINATION COMPRISING LAMIVUDINE
ES2563646T3 (en) Compositions and methods related to protein A (SpA) variants
AU2018256546A1 (en) Combination therapy with peptide epoxyketones
DOP2011000264A (en) AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY
NO20074824L (en) Extension of time to disease progression or survival in cancer patients
MX374396B (en) SUBLINGUAL FENTANYL SPRAY.
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
WO2011035205A3 (en) Antibodies against candida, collections thereof and methods of use
MX365205B (en) Lyophilized preparations of melphalan flufenamide.
MX2009006327A (en) Heterocycle compounds and methods of use thereof.
GB201001602D0 (en) Oligopeptidic compounds and uses therof
PH12013500559A1 (en) Combination therapy for treating hcv infection
ES2530670T3 (en) Anti-FGF23 antibody and pharmaceutical composition comprising the same
MX2009012922A (en) Intradermal hpv peptide vaccination.
GEP20115293B (en) Isolated extract of walnuts, process for its obtaining and its use
EP2166845A4 (en) C-TERMINAL PEPTIDES OF ALPHA CONNEXINE (ACT) TO TREAT AGE-RELATED MACULAR DEGENERATION
NZ594347A (en) Antibodies against human tweak and uses thereof
MY209484A (en) Cpg amphiphiles and uses thereof
NO20054371L (en) Somatostatin-dopamine chimeric analogs
UA102274C2 (en) Epitope peptid rab6kifl/kif20a and vaccines containing it
GB201018125D0 (en) Peptide
EA201101638A1 (en) NEW SOLID FORMS {[(2S, 5R, 8S, 11S) -5-BENZYL-11- (3-GUANIDINOPROPIL) -8-IZOPROPIL-7-METHIL-3,6,9,12,15-PENTAOX-1,4 , 7,10,13-PENTAAZACYCLOPENTAD-2-IL] ACETIC ACID} AND METHODS FOR THEIR RECEIVING
WO2007092607A3 (en) Treatment of hemorrhagic viral infections using a tissue factor inhibitor
WO2007138382A3 (en) Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application